Michael Woudenberg
Vermogen: 2 $ op 31-05-2026
Vermogen: 2 $ op 31-05-2026
Michael Woudenberg is currently Chief Operating Officer at InMed Pharmaceuticals, Inc., a position held since 2022.
Formerly, Mr. Woudenberg was Managing Director at Phyton Biotech LLC.
Mr. Woudenberg completed undergraduate studies at the University of Western Ontario.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 19-12-2025 | 1 ( 0% ) | 2 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| INMED PHARMACEUTICALS INC. | Operationeel Directeur | 15-07-2022 |
| Bedrijven | Functie | Einde |
|---|---|---|
Phyton Biotech LLC
Phyton Biotech LLC BiotechnologyHealth Technology Develops plant molecules | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 3 |
|---|---|
InMed Pharmaceuticals, Inc.
InMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures prescription-based products for dermatology and ocular diseases | Health Technology |
University of Western Ontario
University of Western Ontario Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Phyton Biotech LLC
Phyton Biotech LLC BiotechnologyHealth Technology Develops plant molecules | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau